Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-dose vs single-dose methotrexate for ectopic tubal pregnancy
NCT05208034Completed
- Sponsor
- Nishtar Medical University
- Start
- Jan 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in Ectopic pregnancy (EP), sponsored by Nishtar Medical University. Primary endpoint: Treatment success rate. Started Jan 2020; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT05208034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05208034.